The role of the human papilloma virus in esophageal cancer

Pathology

Volumn 30, Issue 4, 1998, Pages 348-354

  Sur, Monalisa ^a   Cooper, Kum ^a,b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

Author keywords

Carcinogenesis; Esophageal squamous cell cancer; Etiology and pathogenesis; Human papillomavirus; p53 protein; Prevalence

Indexed keywords

PROTEIN P53; RETINOBLASTOMA PROTEIN;

ESOPHAGUS CARCINOMA; GENETIC SUSCEPTIBILITY; HUMAN; REVIEW; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; VIRUS CARCINOGENESIS; WART VIRUS;

EID: 0031740224     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/00313029800169616     Document Type: Article

References (65)

1. Dayne NE, Munoz N. Esophagus. In Schottenfeld D, Fraumeni J, editors. Cancer Epidemiology and Prevention. Philadelphia, PA: Saunders 1982; 596-623.
2. Carter CL, Hu N, Wu M, Lin PZ, Murigande C, Bonney GE, et al. Segregation analysis of esophageal cancer in 221 high risk Chinese families. J Natl Cancer Inst 1992; 84: 771-6.
3. Marger RS, Marger D. Carcinoma of the esophagus and tylosis. A lethal genetic combination. Cancer 1993; 72: 17-9.
4. Ghadirian P. Familial history of esophageal cancer. Cancer 1985; 56: 2112-6.
5. Lu SH, Hsieh LL, Luo FC, Weinstein IB. Amplification of the EGF receptor and c-myc genes in human esophageal cancers. Int J Cancer 1988; 42: 502-5.
6. Jiang W, Zhang YJ, Kahn SM, Hollstein MC, Santella RM, Lu SH. et al. Altered expression of the cyclin D and retinoblastoma genes in human esophageal cancer. Proc Natl Acad Sci USA 1993; 90: 9026-30.
7. Huang Y, Meltzer SJ, Yin J, Tong Y, Chang EH, Srivastava S, et al. Altered messenger RNA and unique mutational profiles of p53 and Rb in human Esophageal carcinomas. Cancer Res 1993; 53: 1889-94.
8. Hollstein MC, Metcalf RA, Walsh JA, Montesano R, Harris CC. Frequent mutations of the p53 gene in human esophageal cancer. Proc Natl Acad Sci USA 1990; 87: 9958-61.
9. Hollstein MC, Smits AM, Galiana C, Hamasaki H, Bos JL, Mandard A, et al. Amplification of epidermal growth factor receptor gene but no evidence of ras mutations in primary human Esophageal cancers. Cancer Res 1988; 48: 5119-23.
10. Zur Hausen H, de Villiers EM. Human papilloma viruses Annu Rev Microbiol 1994; 48: 427-47.
11. Goodner JT, Watson WL. Cancer of the esophagus - its association with other primary cancers. Cancer 1956; 9: 1248-56.
12. Whelan SL, Parkin DM, Masuyer E. Pattern of Cancer in five continents. IARC Scientific Publication No. 102; Lyon: International Agency for Research on Cancer 1990; 14-104.
13. Day NE. The geographic pathology of cancer of the esophagus. The Bed Mull 1984; 40: 329-34.
14. Sons HV. Etiologic and epidemiologic factors of carcinoma of the esophagus. Surg Gynecol Obstet 1987; 165: 183-90.
15. Suzuk L, Amy E, Amy AE, Hui YZ, Frnoglio-Preiser CM. Detection of human papilloma virus in esophageal squamous cell carcinoma. Cancer 1996; 78: 704-10.
16. Syrjanen JJ. Histological changes identical to those of condylomatous lesions found in esophageal squamous cell carcinomas. Arch Geschwulstforsch 1982; 52: 283-92.
17. Mohr IJ, Clark R, Sub S, Androphy EJ, MacPherson P, Botchan MR. Targeting the E replication protein to the papilloma virus origin of replication by complex formation with the E2 transactivator. Science 1990; 250: 1694-9.
18. Chang F, Syrjanen S, Shen Q, Wang L, Syrjanen K. Screening of human papilloma virus infections in esophageal squamous cell carcinoma by in situ hybridization. Cancer 1993; 72: 2525-30.
19. Kahn T, Schwarz F, Zur Hausen H. Molecular cloning and characterization of the DNA of a new human papilloma virus (HPV 30) from a laryngeal carcinoma. Int J Cancer 1986; 37: 61-5.
20. Lu S, Luo F, Li H. Detection of HPV in esophageal squamous cell carcinoma and adjacent tissue specimen in Linxian. Chung Hua Chung Liu Tsa Chih 1995; 17: 321-4.
21. Chen B, Yon H, Dhurandhar N. Detection of Human papilloma virus DNA in esophageal squamous cell carcinoma by the PCR using general consensus primers. Hum Pathol 1994; 25: 920-3.
22. Hua CL, Qiao GB, Hubbert NL, Lil S, Sun CSW, Wang Y, et al. Serologic association between HPV types of 16 infection and esophageal cancer in Shaanxi province, China. J Natl Cancer Inst 1996; 88: 1467-71.
23. He D, Tsao SW, Bu H. Human papillomavirus infection and Esophageal squamous cell carcinoma. Chung Hua Ping Li Hsueh Tsa Chih 1996; 25: 351-4.
24. Kulski J, Demeter T, Sterrett GF, Shilkin KB. Human papilloma virus DNA in Esophageal Carcinoma. Lancet 1986; ii: 683-684.
25. Miller BA, Davidson M, Myerson D, Icenogle J, Lanier AP, Tan J, Beckmann AM. HPV types 16 DNA in Esophageal carcinoma from Alaska natives. Int J Cancer 1997; 71: 218-22.
26. Yang PC, Davis S. Incidence of cancer of Esophagus in the U.S. by histologic type. Cancer 1988; 61: 612-7.
27. Turner JR, Shen LH, Crum CP, Dean PJ, Odze RO. Low prevalence of HPV infection in Esophageal squamous cell carcinoma from North America. Hum Pathol 1997; 28: 174-8.
28. Benamouzig R, Jullian E, Chang F, Robaskiewicz M, Flejou JF, Raoul JL, et al. Absence HPV DNA detected by PCR in French patients with Esophageal carcinoma. Gastroenterology 1995; 109: 1876-91.
29. Togawa K, Jaskiewicz K, Hiroshi T. Human papilloma virus DNA sequences in esophagus squamous cell carcinoma. Gastroenterology 1994; 107: 128-36.
30. Ashworth MT, Mcclicker IW, Sollthern SA, Nash JRG. HPV in squamous cell cancer of the Esophagus associated with tylosis. J Clin Pathol 1993; 46: 573-5.
31. Isaacson C, Selzer G, Kaye V. Cancer in urban blacks of South Africa. S Afr Cancer Bull 1978; 22: 49-84.
32. Editorial: leads in csophageal cancer. Lancet 1974; ii: 504.
33. Williamson AL, Jaskiesicz K, Gunning A. The detection of human papilloma virus in esophageal lesions. Anticancer Res 1991; 11: 263-5.
34. Hille JJ, Margolius KA, Markowitz, S, Isaacson C. HPV infection related to Esophageal cancer in black South Africans. S Afr Med J 1986; 69: 417-20.
35. Cooper K, Taylor L, Govind S. HPV DNA in esophageal carcinoma in South Africa. J Pathol 1995; 175: 273-7.
36. Makoto S, Hashimura M, Takano Y, Ohbu M, Okayasu I. Absence of HPV genomic sequences detected by the PCR in esophageal and gastric carcinoma in Japan. J Clin Pathol Mol Pathol 1997; 50: 101-4.
37. Toh Y, Kuwano H, Tanaka S, Baba K, Matsuda H, Sugimachi K, Mori R. Detection of HPV DNA in esophageal carcinoma in Japan by PCR. Cancer 1992; 70: 2234-8.
38. Mizobuchi S, Sakamoto H, Tachimori Y. Absence of human papilloma virus 16 and 18 DNA and EBV DNA in esophageal squamous cell carcinoma. Jpn J Clin Oncol 1997; 27: 1-5.
39. Loke SL, Ma L, Wong M, Srivastava G, Lo I, Bird CC. HPV in esophageal squamous cell carcinoma. J Clin Pathol 1990; 43: 909-12.
40. Bjorge T, Hakulinen T, Engeland A, Jellum E, Koskela P, Lehtinen M, et al. A prospective sero epidemiological study of the role of HPV in esophageal cancer in Norway. Cancer Res 1997; 57: 3989-92.
41. Battifora H. Immunohistochemistry: a word of caution. Hum Pathol 1994; 25: 435-546.
42. Scheffner M, Werness BA, Huibregste JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by HPV types 16 and 18 promotes the degradation of p53. Cell 1990; 63: 1129-36.
43. Vousden KH, Wrede O, Crook T. HPV oncoprotein function: releasing the breaks on cell growth control. Papilloma Virus Rep 1991; 2: 103.
44. Zur Hausen H. HPV in the pathogenesis of anogenital cancer. Virology 1991; 184: 9-13.
45. Cooper K and Taylor L. p53 protein expression and integrated HPV DNA are not mutually exclusive in esophageal cancer. Cell Vision 1995; 2: 49-51.
46. Baas IO, Mulder JWR, Offerhaus JA, Vogelstein B, Hamilton SR. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms J Pathol 1994; 172: 5-12.
47. Lam KY, He D, Ma L, Zhang D, Ngan HY, Wan TS, Tsao SW. Presence of HPV in esophageal squamous cell carcinoma of Hong Kong Chinese and its relationship with p53 gene mutation. Hum Pathol 1997; 28: 657-63.
48. Nakanishi Y, Noguchi M, Matsuno Y, Saikawa M, Mukai K, Shimosato Y, Hirohishi S. p53 expression in multicentric squamous cell carcinoma and surrounding squamous epithelium of upper aero digestive tract. Cancer 1995; 75: 1657-62.
49. Rugge M, Bovo P, Busatto G, Parenti AR, Fawzy S, Guido M, et al. p53 alterations hut no HPV infection in preinvasive and advanced esophageal squamous cancer in Italy. Cancer Epidemiol Biomarkers Prev 1997; 6: 171-6.
50. Chang F, Syrjanen S, Wang L, Shen Q, Syrjanene K. p53 overexpression and HPV infection in esophageal squamous cell carcinoma derived from a high incidence area in China. Anticancer Res 1997; 17: 709-16.
51. Benamouzig R, Pigot F, Quiroga G, Validire P, Chaussade S, Catalan F, Couturier D. Human papilloma virus infection in esophageal squamous cell carcinoma in western countries. Int J cancer 1992; 50: 549-52.
52. Fidalgo P, Cravo M, Chaves P. High prevalence of human papilloma virus in squamous cell carcinoma and matched normal esophageal mucosa. Cancer 1995; 76: 1522-8.
53. Furihata M, Ohtsuki Y, Ogoshi S, Takahashi A, Tamiya T, Ogata T. Prognostic significance of human papillomavirus genomes (type-16, - 18) and aberrant expression of p53 protein in human esophageal cancer. Int J Cancer 1993; 54: 226-30.
54. Kiyabu MT, Shibata D, Arnheim N, John Martin W, Fitzgibbons PL. Detection of human papilloma virus in formalin fixed, invasive squamous carcinomas using the polymerase chain reaction. Am J surg Pathol 1989; 13: 221-4.
55. Poljak M, Cerar A. Human papilloma virus type 16 DNA in esophageal squamous cell carcinoma. Anticancer Res 1993; 13: 2113-6.
56. Smits HL, Tjong A, Hung SP, Schegget J, Nooter K, Kok T. Absence of human papilloma virus DNA from esophageal carcinoma as determined by multiple broad spectrum polymerase chain reactions. J Med Virol 1995; 46: 213-5.
57. Choo KB, Pan CC, Han SH. Integration of human papilloma virus type 16 into cellular DNA of cervical carcinoma. Preferential Deletion of the E2 gene and invariable retention of the long control region and the E6/E7 open reading frames. Virology 1987; 161: 259-61.
58. Bauer HM, Gmer CE, Manos MM. Determination of genital HPV infection by consensus PCR amplification. In: Diagnostic Molecular Pathology: a Practical Approach. Vol 2. Oxford: Oxford University Press 1992; 131-51.
59. Noffsinger AE, Suzuk K, Hui YZ, Gal AA, Frnoglio-Preiser CM. Differential sensitivities of E6 types specific and L1 consensus primers in the detection of HPV in anal carcinoma. Mod Pathol 1995; 8: 509-14.
60. Werness BA, Levine AJ, Howley PM. The E6 proteins encoded by Human Papilloma Virus Type 16 and 18 can complex p53 in vitro. Science 1990; 248: 76-9.
61. Dyson N, Howley PM, Munger K, Harlow E. The Human Papilloma Virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989; 243: 934-6.
62. Chang F, Syrjanen S, Kurvinen K, Syrjanen K. The p53 tumor suppressor gene as a common cellular target in human carcinogenesis. Am J Gastroenterol 1993; 88: 174-86.
63. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991; 253: 49-53.
64. Bennett WP, Hollstein MC, Metcalf RA, Welsch JA, He A, Zhu SM. et al. p53 mutation and protein accumulation during multistage human esophageal carcinogenesis. Cancer Res 1992; 52: 6092-7.
65. Huang Y, Boynlon RF, Blount PL, Silverstein RJ, Yin J, Tong Y, et al. Loss of heterozygocity involves multiple tumor suppressor genes in human esophageal cancers. Cancer Res 1992; 52: 6525-30.